RSLBX
Price
$55.92
Change
-$0.92 (-1.62%)
Updated
Sep 6 closing price
WASIX
Price
$11.37
Change
-$0.17 (-1.47%)
Updated
Sep 6 closing price
Ad is loading...

RSLBX vs WASIX

Header iconRSLBX vs WASIX Comparison
Open Charts RSLBX vs WASIXBanner chart's image
American Funds SMALLCAP World R2
Price$55.92
Change-$0.92 (-1.62%)
VolumeN/A
CapitalizationN/A
Seven Canyons Strategic Global Investor
Price$11.37
Change-$0.17 (-1.47%)
VolumeN/A
CapitalizationN/A
View a ticker or compare two or three
RSLBX vs WASIX Comparison Chart
Loading...
VS
RSLBX vs. WASIX commentary
Sep 08, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is RSLBX is a StrongSell and WASIX is a Sell.

FUNDAMENTALS
Fundamentals
RSLBX has more cash in the bank: 72.2B vs. WASIX (13.8M). WASIX pays higher dividends than RSLBX: WASIX (2.30) vs RSLBX (0.15). RSLBX was incepted earlier than WASIX: RSLBX (22 years) vs WASIX (19 years). WASIX is a more actively managed with annual turnover of: 102.00 vs. RSLBX (29.00). RSLBX has a lower initial minimum investment than WASIX: RSLBX (250) vs WASIX (2000). WASIX annual gain was more profitable for investors over the last year : 11.19 vs. RSLBX (8.93). RSLBX return over 5 years is better than : 13.92 vs. WASIX (5.97).
RSLBXWASIXRSLBX / WASIX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence22 years19 years-
Gain YTD1.2475.03725%
Front LoadN/AN/A-
Min. Initial Investment250200013%
Min. Initial Investment IRAN/AN/A-
Net Assets72.2B13.8M523,188%
Annual Yield % from dividends0.152.306%
Returns for 1 year8.9311.1980%
Returns for 3 years-30.27-29.65102%
Returns for 5 years13.925.97233%
Returns for 10 years19.347.30265%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
LFCR4.590.37
+8.77%
Lifecore Biomedical
MSN0.470.03
+5.74%
Emerson Radio Corp
CNH10.130.02
+0.20%
CNH Industrial NV
AMED97.16-0.52
-0.53%
Amedisys
EMBC15.15-1.29
-7.85%
Embecta Corp